Aravive Stock Working Capital
| ARAVDelisted Stock | USD 1.49 0.21 12.35% |
Aravive fundamentals help investors to digest information that contributes to Aravive's financial success or failures. It also enables traders to predict the movement of Aravive Stock. The fundamental analysis module provides a way to measure Aravive's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aravive stock.
Aravive |
Aravive Company Working Capital Analysis
Aravive's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Aravive Working Capital | 35.86 M |
Most of Aravive's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aravive is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionIn accordance with the company's disclosures, Aravive has a Working Capital of 35.86 M. This is 91.58% lower than that of the Biotechnology sector and 93.34% lower than that of the Health Care industry. The working capital for all United States stocks is 97.57% higher than that of the company.
Aravive Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aravive's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aravive could also be used in its relative valuation, which is a method of valuing Aravive by comparing valuation metrics of similar companies.Aravive is currently under evaluation in working capital category among its peers.
Aravive Fundamentals
| Return On Equity | -4.76 | |||
| Return On Asset | -1.34 | |||
| Operating Margin | (3.23) % | |||
| Current Valuation | (3.16 M) | |||
| Shares Outstanding | 73.56 M | |||
| Shares Owned By Insiders | 38.68 % | |||
| Shares Owned By Institutions | 8.20 % | |||
| Number Of Shares Shorted | 1.33 M | |||
| Price To Earning | 3.34 X | |||
| Price To Book | 1.73 X | |||
| Price To Sales | 0.42 X | |||
| Revenue | 6.99 M | |||
| Gross Profit | (57.8 M) | |||
| EBITDA | (58.4 M) | |||
| Net Income | (39.85 M) | |||
| Cash And Equivalents | 46.83 M | |||
| Cash Per Share | 1.53 X | |||
| Total Debt | 6.27 M | |||
| Debt To Equity | 0.17 % | |||
| Current Ratio | 2.39 X | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | (59.45 M) | |||
| Short Ratio | 0.91 X | |||
| Earnings Per Share | (0.76) X | |||
| Target Price | 0.25 | |||
| Number Of Employees | 23 | |||
| Beta | 2.19 | |||
| Market Capitalization | 2.95 M | |||
| Total Asset | 62.15 M | |||
| Retained Earnings | (616.13 M) | |||
| Working Capital | 35.86 M | |||
| Current Asset | 60.74 M | |||
| Current Liabilities | 11.48 M | |||
| Z Score | -15.89 | |||
| Net Asset | 62.15 M |
About Aravive Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aravive's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aravive using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aravive based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Aravive Stock
If you are still planning to invest in Aravive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aravive's history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |